FinancialNirvana.com

Yahoo - Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) said on Thursday that it has received final approval from the Food and Drug Administration (FDA) for its generic version of allergy medication Allegra, and will begin commercial marketing immediately.

The stock is near its 52 week high but the downturn in the Indian market the last couple of days is clearly affecting the stock.

Share This

• Dr. Reddy’s launches generic Proscar and Zocor in US
• Indian Stocks Weekly Report - Week ending December 10, 2006
• Infosys surpasses Billion Revenue mark. Will reward shareholders via special dividend
• Indian Stocks to keep an eye on during this downturn
• Companies that make up the BSE SENSEX